Zdrowie i gospodarka · 07/08/2009

FDA Releases Guidance to Prevent Melamine Contamination in Pharmaceuticals

The Food and Drug Administration (FDA) has made available a guidance document to help pharmaceutical manufacturers and pharmacists identify and avoid components at risk of melamine contamination, a contaminant that has been linked to health issues in the past.